腹腔镜肝切除治疗肝细胞癌的安全性和长期疗效观察

doi:10.3969/j.issn.1009-976X.2022.05.002

摘要/Abstract

摘要： 目的探讨腹腔镜肝切除治疗肝细胞癌的安全性及长期疗效。方法回顾性分析2014年1月至2019年12月间在佛山市第一人民医院诊治的197例肝细胞癌患者的手术时间、中转开腹率、术中出血、术中输血量及术后并发症等围术指标,术后平均住院时间、肿瘤复发率、无瘤生存率,术后1、3、5年总的生存期等数据。结果术中出血量为263.59±252.9 mL,手术时间为320.5±119.56 min。无围手术期死亡病例,术后发生腹腔积液9例（4.6%）,胸腔积液9例（4.6%）,胆漏3例（1.5%）,术后出血4例（2.0%）,术后肺炎2例（1.0%）,术后总并发症发生率为13.7%（27/197）。术后住院时间为8.9±3.63天。随访至2021年6月1日,共有67例患者肿瘤复发,无瘤中位生存时间为78个月,复发率34%。术后1、3、5年无瘤生存期分别为84.2%、65.2%、59.4%。术后1、3、5年总生存期分别为96.3%、86.8%、83.6%。结论腹腔镜肝切除治疗肝细胞癌是安全可行的,长期疗效与开腹肝切除无明显差异。

关键词: 腹腔镜肝切除, 安全性, 长期疗效

Abstract: Objective To Investigate the safety and long-term efficacy of laparoscopic liver resection for patients with hepatocellular carcinoma. Methods The clinical data of 197 hepatocellular carcinoma patients with treated in Foshan First People′s Hospital from January 2014 to December 2019 were retrospectively analyzed. The data were analyzed for their perioperative indexes such as operative time, intermediate open rate, intraoperative blood loss, intraoperative blood transfusion and postoperative complications, mean postoperative hospital stay, tumor recurrence rate, tumor-free survival rate, and overall survival at 1, 3 and 5 years after surgery. Results There were no deaths during the perioperative period. Intraoperative blood loss was 263. 59±; 252. 9 mL, the operation time was 320. 5±; 119. 56 min. There was no perioperative death, no postoperative liver failure, no postoperative wound infection; 9 cases of abdominal effusion, 9 cases of pleural effusion after operation. There were 3 cases of bile leakage, 4 cases of postoperative bleeding, and 2 cases of postoperative pneumonia. The total complication rate was 13. 7%. The postoperative hospital stay was 8.9±; 3.63 days. Followed up until June 1 2021, a total of 67 patients had tumor recurrence. The median tumor-free survival time was 78 months, and the recurrence rate was 34%. The tumor-free survival at 1, 3, and 5 years after surgery was 84. 2%, 65. 2%, and 59. 4%. The overall survival period of 1, 3, and 5 years after operation was 96. 3%, 86. 8%, and 83. 6%. Conclusion Laparoscopic hepatectomy for hepatocellular carcinoma is safe and feasible, its long-term outcomes do not differ significantly from those of open hepatectomy.

Key words: laparoscopic liver resection, safety, long-term efficacy

中图分类号:

R657.3

罗发, 严庆, 陈焕伟. 腹腔镜肝切除治疗肝细胞癌的安全性和长期疗效观察[J]. 岭南现代临床外科, 2022, 22(05): 441-445.

LUO Fa, YAN Qing, CHEN Huan-wei. Observation of the safety and long-term efficacy of laparoscopic liver resection for the treatment of hepatocellular carcinoma[J]. Lingnan Modern Clinics In Surgery, 2022, 22(05): 441-445.

参考文献

[1] 中华人民共和国国家卫生健康委员会医政医管局. 原发性肝癌诊疗规范(2019年版)[J]. 中华消化外科杂志, 2020, 19(1): 1-20.
[2] Njei B, Rotman Y, Ditah I, et al.Emerging trends in hepatocellular carcinoma incidence and mortality[J]. Hepatology, 2015, 61(1):191-199.
[3] 周伟平, 孙志宏, 吴孟超, 等. 经腹腔镜肝叶切除首例报道[J]. 肝胆外科杂志, 1994, (2): 82.
[4] Buell JF, Cherqui D, Geller DA, et al.The international position on laparoscopic liver surgery: The Louisville Statement, 2008[J]. Ann Surg, 2009, 250(5): 825-830.
[5] 中国研究型医院学会肝胆胰外科专业委员会. 腹腔镜肝切除术治疗肝细胞癌中国专家共识(2020版)[J]. 中华消化外科杂志, 2020, 19(11): 1119-1134.
[6] Araki K, Kubo N, Watanabe A, et al.Systematic review of the feasibility and future of laparoscopic liver resection for difficult lesions[J]. Surg Today, 2018, 48(7): 659-666.
[7] Wakabayashi G, Cherqui D, Geller DA, et al.Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka[J]. Ann Surg, 2015, 261(4): 619-29.
[8] 方驰华,张鹏,周伟平,等.三维可视化技术用于1665例原发性肝癌精准诊治的多中心回顾性研究[J].中华外科杂志,2020,58(5):375-382.
[9] Felli E, Ishizawa T, Cherkaoui Z, et al.Laparoscopic anatomical liver resection for malignancies using positive or negative staining technique with intraoperative indocyanine green-fluorescence imaging[J]. HPB (Oxford), 2021, 23(11):1647-1655.
[10] 王鹏, 王宏光. 腹腔镜超声肝内管道结构的辨识[J]. 岭南现代临床外科, 2021, 21(4): 392-396.
[11] Chen HW, Deng FW, Hu JY, et al.Extra-glissonian Approach for Total Laparoscopic Left Hepatectomy: A Prospective Cohort Study[J]. Surg Laparosc Endosc Percutan Tech, 2017, 27(6): e145-e148.
[12] 王峰杰, 陈焕伟, 邓斐文, 等. 腹腔镜优先Glisson鞘外阻断肝右前叶切除术治疗肝细胞癌[J]. 中华肝脏外科手术学电子杂志, 2021, 10(3): 322-325.
[13] Chen HW, Wang FJ, Li JY, et al. Extra-Glissonian Approach for Laparoscopic Liver Right Anterior Sectionectomy [J]. JSLS, 2019, 23(2): e2019.00009.
[14] Liu TS, Shen QH, Zhou XY,et al.Application of controlled low central venous pressure during hepatectomy: A systematic review and meta-analysis[J]. J Clin Anesth, 2021, 75: 110467.
[15] 张岳农, 罗荣, 邓靖单, 等. 控制性低中心静脉压技术在腹腔镜肝切除术中的临床应用[J]. 岭南现代临床外科, 2017, 17(4): 423-427,431.
[16] Smith AA, Monlezun DJ, Martinie J, et al.Bile Leak Reduction with Laparoscopic Versus Open Liver Resection: A Multi-institutional Propensity Score-Adjusted Multivariable Regression Analysis[J]. World J Surg, 2020, 44(5): 1578-1585.
[17] Troisi RI, Berardi G, Morise, Z, et al.Laparoscopic and open liver resection for hepatocellular carcinoma with Child-Pugh B cirrhosis: multicentre propensity score-matched study[J]. Br J Surg, 2021, 108(2): 196-204.
[18] Aoki T, Kubota K, Matsumoto T, et al.Safety assessment of laparoscopic liver resection: A project study of the Endoscopic Liver Surgery Study Group of Japan[J]. J Hepatobiliary Pancreat Sci, 2021, 28(6): 470-478.
[19] Sun Q, Zhang X, Gong X, et al.Survival analysis between laparoscopic and open hepatectomy for hepatocellular carcinoma: a meta-analysis based on reconstructed time-to-event data[J]. Hepatol Int, 2021, 15(5): 1215-1235.
[20] Goh BKP, Syn N, Koh YX, et al.Comparison between short and long-term outcomes after minimally invasive versus open primary liver resections for hepatocellular carcinoma: A 1: 1 matched analysis[J]. J Surg Oncol, 2021, 124(4): 560-571.
[21] Lee DH, Kim D, Park YH, et al.Long-term surgical outcomes in patients with hepatocellular carcinoma undergoing laparoscopic vs. open liver resection: A retrospective and propensity score-matched study[J]. Asian J Surg, 2021, 44(1): 206-212.
[22] Cheung TT, Ma KW, She WH, et al.Zero Hospital Mortality and Improved Long Tern Survival in Laparoscopic Hepatectomy for Patients with HCC -A Propensity Score Analysis of 836 Patients[J]. HPB, 2021, 23(S1): S37.
[23] Yoon YI,Kim KH, Cho HD, et al.Long-term perioperative outcomes of pure laparoscopic liver resection versus open liver resection for hepatocellular carcinoma: a retrospective study[J]. Surg Endosc, 2020, 34(2): 796-805.
[24] Wu X, Huang Z, Lau WY, et al.Perioperative and long-term outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma with well-preserved liver function and cirrhotic background: a propensity score matching study[J]. Surg Endosc, 2019, 33(1): 206-215.
[25] Tsai KY, Chen HA, Wang WY, et al.Long-term and short-term surgical outcomes of laparoscopic versus open liver resection for hepatocellular carcinoma: might laparoscopic approach be better in early HCC?[J]. Surg Endosc, 2019, 33(4): 1131-1139.